PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
100 hedge funds and large institutions have $121M invested in Paratek Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 15 closing their positions.
Holders
100
Holders Change
+1
Holders Change %
+1.01%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
17
Increased
33
Reduced
29
Closed
15
Calls
$2.21M
Puts
$399K
Net Calls
+$1.81M
Net Calls Change
+$1.04M
Top Buyers
| 1 |
BC
1
Bruce & Co
Chicago,
Illinois
|
$4.76M |
| 2 |
2
BlackRock
New York
|
$16.4M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$11.2M |
| 4 |
WVP
4
Worth Venture Partners
Fort Lee,
New Jersey
|
$933K |
| 5 |
GAI
5
General American Investors
New York
|
$5.41M |
Top Sellers
| 1 |
1
D.E. Shaw & Co
New York
|
$3.33M |
| 2 |
2
Morgan Stanley
New York
|
$2.96M |
| 3 |
BBVA
3
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
$0 |
| 4 |
4
Squarepoint
New York
|
$169K |
| 5 |
WIC
5
Water Island Capital
New York
|
$1.22M |
